Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Appointed director Inv. presentation Director departure Quarterly results
|
Protalix BioTherapeutics, Inc. (PLX)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
01/03/2023 |
SC 13G/A
| NACHT MARIUS reports a 5.3% stake in Protalix BioTherapeutics, Inc. |
02/14/2022 |
SC 13G/A
| HIGHBRIDGE CAPITAL MANAGEMENT LLC reports a 5% stake in Protalix BioTherapeutics, Inc. |
02/11/2022 |
SC 13G/A
| HIGHBRIDGE CAPITAL MANAGEMENT LLC reports a 0% stake in Protalix BioTherapeutics, Inc. |
01/31/2022 |
SC 13G/A
| NACHT MARIUS reports a 5.8% stake in Protalix BioTherapeutics, Inc. |
07/30/2021 |
SC 13G/A
| Burrage Capital Management LLC reports a |
06/15/2021 |
SC 13G/A
| Dexcel Pharma Technologies Ltd. reports a 4.5% stake in Protalix BioTherapeutics, Inc. |
02/16/2021 |
SC 13G/A
| Dexcel Pharma Technologies Ltd. reports a 10.3% stake in Protalix BioTherapeutics, Inc. |
02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/09/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/08/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/08/2021 |
SC 13G/A
| NACHT MARIUS reports a 10% stake in Protalix BioTherapeutics, Inc. |
03/09/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/13/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/13/2020 |
SC 13G/A
| O'Connor Global Multi-Strategy Alpha Master Ltd reports a 0% stake in Protalix Biotherapeutics, Inc. |
02/07/2020 |
SC 13G/A
| CITIGROUP INC reports a 5.8% stake in Protalix BioTherapeutics, Inc. |
02/12/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/12/2019 |
SC 13G/A
| O'Connor Global Multi-Strategy Alpha Master Ltd reports a 6% stake in Protalix Biotherapeutics, Inc. |
02/08/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/13/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/13/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/12/2018 |
SC 13G/A
| O'Connor Global Multi-Strategy Alpha Master Ltd reports a 6% stake in Protalix Biotherapeutics, Inc. |
01/25/2018 |
SC 13G/A
| Abir Therapeutics Ltd reports a 0% stake in – Exit Filing)* PROTALIX BIOTHERAPEUTICS, INC. |
07/10/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/23/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/15/2017 |
SC 13G/A
| O'Connor Global Multi-Strategy Alpha Master Ltd reports a 9.5% stake in Protalix Biotherapeutics, Inc. |
02/14/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
02/14/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
02/14/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
01/04/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
04/07/2016 |
SC 13G/A
| Delek Group, Ltd. reports a 2.4% stake in Protalix BioTherapeutics, Inc. |
02/08/2016 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
02/12/2013 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
02/10/2012 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
01/17/2012 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
|
|